Thrivent Financial for Lutherans
ZOM

Thrivent Financial for Lutherans’s Zomedica Corp. ZOM Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,925
Closed -$3K – 2590
2024
Q4 		$3K Hold
20,925
– – ﹤0.01% 2548
2024
Q3 		$3K Hold
20,925
– – ﹤0.01% 2506
2024
Q2 		$3K Hold
20,925
– – ﹤0.01% 2519
2024
Q1 		$3K Hold
20,925
– – ﹤0.01% 2503
2023
Q4 		$4K Hold
20,925
– – ﹤0.01% 2479
2023
Q3 		$4K Hold
20,925
– – ﹤0.01% 2428
2023
Q2 		$4K Hold
20,925
– – ﹤0.01% 2456
2023
Q1 		$4K Hold
20,925
– – ﹤0.01% 2432
2022
Q4 		$3K Hold
20,925
– – ﹤0.01% 2406
2022
Q3 		$4K Hold
20,925
– – ﹤0.01% 2400
2022
Q2 		$5K Hold
20,925
– – ﹤0.01% 2405
2022
Q1 		$7K Buy
+20,925
New +$6.85K ﹤0.01% 2493
2021
Q4 		– Hold
0
– – – 2457
2021
Q3 		– Hold
0
– – – 2465
2021
Q2 		– Hold
0
– – – 2449
2021
Q1 		– Hold
0
– – – 2518

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Thrivent Financial for Lutherans's ZOM Position: Q1 2025 in Review

Thrivent Financial for Lutherans sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 20,925 shares — an estimated $3K sold.

Thrivent Financial for Lutherans first reported a position in ZOM in Q1 2022 and held it in 12 quarters. The position peaked at $7K in Q1 2022. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Thrivent Financial for Lutherans reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 20,925 Zomedica Corp. shares in Q1 2025, an estimated $3K.
  • Thrivent Financial for Lutherans first reported a position in Zomedica Corp. in Q1 2022 and held it in 12 quarters.
  • Thrivent Financial for Lutherans's Zomedica Corp. position peaked at $7K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2025, filed 13 May 2025.